Fgcsic Obtains 8 Million for a Research Project

The Fundación General del Consejo Superior de Investigaciones Científicas (Fgcsic) is committed to seniors. The entity has signed a collaboration agreement with Goya Global Holding (GGH) to develop a project on prolonging the autonomous life of the aging population.

Ramón Torrecillas, CEO of the Foundation, and Sergio Vidal, CEO of GGH, have agreed to develop cooperative projects in which the private party will invest more than eight million euros.

The Life Data project studies how the autonomous and active life of the elderly can be prolonged as much as possible in their aging process. Through the application of advanced architectural space sensing and artificial intelligence (AI) technologies, this project aims to create a data space that respects the sovereignty, security and privacy of the elderly.

The exploitation of this data will make it possible to act on the senior population to maximize their vital autonomy and activity, and to maintain their health at optimal levels. This will make it possible to make the public health system more sustainable and provide it with greater quality, according to Fgcsic in a press release.

Read more on the subject and find the latest business headlines with the Born2Invest mobile app. Our companion app keeps its readers up to date with the most important updates in the financial world and with the latest investments in the biotech sector.

Fgcsic will rely on sensorization and AI technologies to learn how to prolong the lives of the elderly

GGH has partnered with Fgcsic as part of its strategy to expand its senior living project, Forum/The Comm. Its customers are mostly fully autonomous seniors whom GGH wants to offer to remain independent for as long as possible.

The company’s initial forecasts include the construction of 2,000 rental homes that would incorporate the developed technology. In the first phase, GGH is contributing close to one million euros to finance the proofs of concept that will make way for the pilot that will constitute the second phase.

The objective of this agreement is to incorporate a non-invasive and transparent sensorization system for each dwelling, which will make it possible to detect early signs of frailty through the processing of the data obtained and to propose personalized interventions to delay as much as possible the entry into dependence.

Beyond its business application, Datos de Vida, as an initiative for the digitalization of healthcare services, will allow its extrapolation to the rest of the population, facilitating the prevention of multiple pathologies, the remote care of chronic patients, and the prolongation of an active and healthy life, according to the organization.

__

(Featured image by sabinevanerp via Pixabay)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in PlantaDoce, a third-party contributor translated and adapted the articles from the originals. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.